Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers

American Journal of Pathology

Volumn 156, Issue 2, 2000, Pages 409-417

  Chan, Wood Yee ^a   Cheung, Kwok Kuen ^a   Schorge, John O ^b,d   Huang, Lee Wen ^b,d   Welch, William R ^b,d   Bell, Debra A ^b,c,d   Berkowitz, Ross S ^b,d   Mok, Samuel C ^b,d  

^a Prince of Wales Hospital   (Hong Kong)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; NICK END LABELING; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033901471     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64744-X     Document Type: Article

References (65)

1. The epidemiology of ovarian cancer
2. Cancer of the ovary
3. Molecular approaches to prevention and detection of epithelial ovarian cancer
4. DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer
5. Immunohistochemically detected p53 and HER-2/neu expression and nuclear DNA content in familial epithelial ovarian carcinomas
6. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy
7. K-ras mutations in mucinous ovarian tumors
8. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells
9. Contribution of BRCA1 mutations to ovarian cancer
10. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer
11. The genetic regulation of apoptosis
12. Bcl-2 and the regulation of programmed cell death
13. DNA rearrangements in human follicular lymphoma can involved the 5' or the 3' region of the bcl-2 gene
14. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
15. Bcl-2 protein in non-small-cell lung carcinoma
16. High prevalence of bcl-2 expression in small cell lung cancer
17. Human gliomas with wild-type p53 express bcl-2
18. Bcl-2 protooncogene expression in epstein-barr virus associated nasopharyngeal carcinoma
19. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas
20. The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and bcl-2
21. Participation of p53 protein in the cellular response to DNA damage
22. A mammalian celt cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia
23. Introduction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
24. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6
25. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
26. Implications of p53 tumor-suppressor gene in clinical oncology
27. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer
28. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy
29. p53 Mutation is a common genetic event in ovarian carcinoma
30. Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small-cell lung cancer
31. Overexpression of bcl-2 and mutation in p53 and K-ras in resected human non-small-cell lung cancers
32. Immunohistochemical detection of p53, bcl-2 and retinoblastoma proteins in follicular lymphoma
33. Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia
34. Bcl-2 and p53 immunophenotypes in pre-malignant, early and advanced esophageal squamous cancer
35. Bcl-2 versus p53 protein expression and apoptotic rate in human nonmelanoma skin cancers
36. Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: Their correlation with Ki-67 growth fraction
37. Expression of bcl-2 in human breast cancer: Correlation between hormone receptor status, p53 protein accumulation and DNA strand breaks associated with apoptosis
38. Combined analysis with bcl-2 and p53 immunostaining predicts poorer prognosis in prostatic carcinoma
39. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas
40. Expression and prognostic significance of Bcl-2 in ovarian tumors
41. Changes in definitions of clinical staging for carcinoma of the cervix and ovary
42. Apoptosis and bcl-2 oncoprotein expression in the human fetal central nervous system
43. bcl-2 and p53 Oncoprotein expression during colorectal tumorgenesis
44. Unifocal origin of advanced human epithelial ovarian cancer
45. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
46. Differentiation between cellular apoptosis and necrosis by combined use of in situ tailing and nick translation techniques
47. Over-expression and mutation of p53 in epithelial ovarian cancer
48. Bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas
49. Identification of a p53-dependent negative response element in the bcl-2 gene
50. Down-regulation of bcl-2 in human breast cancer cells
51. Immunohistochemical detection of p53 protein in HPV positive oral lesions
52. Analysis of transforming growth factor (TGF)-α/epidermal growth factor receptor, hepatocyte growth factor/c-met, TGF-β receptor type II, and p53 expression in human hepatocellular carcinomas
53. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis
54. p53 Protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix
55. p53 Gene mutation in human borderline epithelial ovarian tumors
56. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis
57. Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells
58. Bcl-2 expression is widespread in the developing nervous and retained in the adult PNS
59. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis
60. Protein expression during murine development
61. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death
62. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line
63. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis
64. Differential sensitivity to AdS E1B-21kD and bcl-2 proteins of apoptin-induced apoptosis